Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injuryAnnayya R. Aroor, Vincent G. DeMarco|Cardiovascular Diabetology|2018Cited by 177
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceAnnayya R. Aroor, Vincent G. DeMarco|Cardiovascular Diabetology|2017Cited by 70